These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 38780637)

  • 1. [CAR T-cell therapy in rheumatology-What we know so far?].
    Hagen M; Wirsching A; Bohr D; Taubmann J; Müller F; Mackensen A; Grieshaber-Bouyer R; Schett G
    Z Rheumatol; 2024 Aug; 83(6):485-491. PubMed ID: 38780637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is There a Place for Chimeric Antigen Receptor-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
    Orvain C; Boulch M; Bousso P; Allanore Y; Avouac J
    Arthritis Rheumatol; 2021 Nov; 73(11):1954-1965. PubMed ID: 34042325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric antigen receptor T cell therapy: a new emerging landscape in autoimmune rheumatic diseases.
    Lyu X; Gupta L; Tholouli E; Chinoy H
    Rheumatology (Oxford); 2024 May; 63(5):1206-1216. PubMed ID: 37982747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the role of CAR T-cell therapy: From B-cell hematological malignancies to autoimmune rheumatic diseases.
    Shumnalieva R; Velikova T; Monov S
    Int J Rheum Dis; 2024 May; 27(5):e15182. PubMed ID: 38742463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing autoimmune Rheumatic disease treatment: CAR-T Cell Therapies - Evidence, Safety, and future directions.
    Ohno R; Nakamura A
    Semin Arthritis Rheum; 2024 Aug; 67():152479. PubMed ID: 38810569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancements and challenges in CAR T cell therapy in autoimmune diseases.
    Schett G; Müller F; Taubmann J; Mackensen A; Wang W; Furie RA; Gold R; Haghikia A; Merkel PA; Caricchio R; D'Agostino MA; Locatelli F; June CH; Mougiakakos D
    Nat Rev Rheumatol; 2024 Sep; 20(9):531-544. PubMed ID: 39107407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAR-T-Cell Therapy for Systemic Lupus Erythematosus: A Comprehensive Overview.
    Abdalhadi HM; Chatham WW; Alduraibi FK
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontiers in CAR-T cell therapy for autoimmune diseases.
    Li YR; Lyu Z; Chen Y; Fang Y; Yang L
    Trends Pharmacol Sci; 2024 Sep; 45(9):839-857. PubMed ID: 39147651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAR T-Cell Therapy in Autoimmune Disease. Reply.
    Müller F; Mackensen A; Schett G
    N Engl J Med; 2024 May; 390(17):1631-1632. PubMed ID: 38692300
    [No Abstract]   [Full Text] [Related]  

  • 10. CAR T-Cell Therapy in Autoimmune Disease.
    Howard JF; Vu T; Mozaffar T
    N Engl J Med; 2024 May; 390(17):1629-1631. PubMed ID: 38692299
    [No Abstract]   [Full Text] [Related]  

  • 11. Dawn of CAR-T cell therapy in autoimmune diseases.
    Liu Y; Dong M; Chu Y; Zhou L; You Y; Pang X; Yang S; Zhang L; Chen L; Zhu L; Xiao J; Wang W; Qin C; Tian D
    Chin Med J (Engl); 2024 May; 137(10):1140-1150. PubMed ID: 38613216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAR T-cell therapy in autoimmune diseases.
    Schett G; Mackensen A; Mougiakakos D
    Lancet; 2023 Nov; 402(10416):2034-2044. PubMed ID: 37748491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAR T-Cell Therapy in Autoimmune Disease.
    Merkt W; Lorenz HM; Schmitt M
    N Engl J Med; 2024 May; 390(17):1628-1629. PubMed ID: 38692297
    [No Abstract]   [Full Text] [Related]  

  • 14. CAR T-Cell Therapy in Autoimmune Disease.
    De Benedetti F; Diomedi Camassei F; Locatelli F
    N Engl J Med; 2024 May; 390(17):1629. PubMed ID: 38692298
    [No Abstract]   [Full Text] [Related]  

  • 15. CAR immunotherapy in autoimmune diseases: promises and challenges.
    Yu J; Yang Y; Gu Z; Shi M; La Cava A; Liu A
    Front Immunol; 2024; 15():1461102. PubMed ID: 39411714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAR-T cells for treating systemic lupus erythematosus: A promising emerging therapy.
    Guffroy A; Jacquel L; Guffroy B; Martin T
    Joint Bone Spine; 2024 Sep; 91(5):105702. PubMed ID: 38336271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fully Human Anti-CD19 CAR T Cells Derived from Systemic Lupus Erythematosus Patients Exhibit Cytotoxicity with Reduced Inflammatory Cytokine Production.
    Dingfelder J; Aigner M; Taubmann J; Minopoulou I; Park S; Kaplan CD; Cheng JK; Van Blarcom T; Schett G; Mackensen A; Lutzny-Geier G
    Transplant Cell Ther; 2024 Jun; 30(6):582.e1-582.e10. PubMed ID: 38548226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-the-shelf CAR-T cells could prove paradigm shifting for autoimmune diseases.
    Baker DJ; June CH
    Cell; 2024 Sep; 187(18):4826-4828. PubMed ID: 39241743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highlight of 2023: CAR T cells driving precision therapy for autoimmune disease.
    Lee AY; Reed JH
    Immunol Cell Biol; 2024 Jul; 102(6):437-440. PubMed ID: 38693765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy?
    Shah K; Leandro M; Cragg M; Kollert F; Schuler F; Klein C; Reddy V
    Clin Exp Immunol; 2024 Jun; 217(1):15-30. PubMed ID: 38642912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.